Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial - Archive ouverte HAL Access content directly
Journal Articles PLoS Pathogens Year : 2020

Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial

(1, 2) , (1) , (3) , (4) , (1) , (2) , (5) , (6) , (3) , (1) , (1) , (7) , (8) , (8) , (1) , (9) , (9) , (9) , (10) , (10) , (11) , (12) , (4) , (13) , (3)
1
2
3
4
5
6
7
8
9
10
11
12
13
Yves Lévy
Vaccine Research Institute
CHU Henri Mondor
Christine Lacabaratz
Vaccine Research Institute
Kim Ellefsen-Lavoie
  • Function : Author
Centre Hospitalier Universitaire Vaudois [Lausanne]
Wolfgang Stöhr
  • Function : Author
University College of London [London]
Jean-Daniel Lelièvre
Vaccine Research Institute
Pierre-Alexandre Bart
  • Function : Author
CHU Henri Mondor
Odile Launay
Assistance publique - Hôpitaux de Paris (AP-HP)
Jonathan Weber
Imperial College London
CV
Bernd Salzberger
  • Function : Author
Centre Hospitalier Universitaire Vaudois [Lausanne]
Aurélie Wiedemann
Vaccine Research Institute
Mathieu Surénaud
  • Function : Author
Vaccine Research Institute
David Koelle
  • Function : Author
University of Washington [Seattle]
Hans Wolf
  • Function : Author
Universität Regensburg
Ralf Wagner
  • Function : Author
Universität Regensburg
Véronique Rieux
  • Function : Author
Vaccine Research Institute
David Montefiori
  • Function : Author
Duke University Medical Center
Nicole Yates
  • Function : Author
Duke University Medical Center
Georgia Tomaras
  • Function : Author
Duke University Medical Center
Raphael Gottardo
  • Function : Author
Fred Hutchinson Cancer Research Center [Seattle]
Bryan Mayer
  • Function : Author
Fred Hutchinson Cancer Research Center [Seattle]
Song Ding
  • Function : Author
EuroVacc Foundation
Rodolphe Thiébaut
Statistics In System biology and Translational Medicine
CV
Sheena Mccormack
  • Function : Author
University College of London [London]
Geneviève Chêne
  • Function : Author
Bordeaux population health
Giuseppe Pantaleo
Centre Hospitalier Universitaire Vaudois [Lausanne]

Domains

Life Sciences [q-bio]

SANDRINE DARMIGNY  : Connect in order to contact the contributor

https://hal.inria.fr/hal-03142733

Submitted on : Tuesday, February 16, 2021-11:43:20 AM

Last modification on : Thursday, December 22, 2022-10:17:19 AM

Consult the full text

Dates and versions

hal-03142733 , version 1 (16-02-2021)

Identifiers

Cite

Yves Lévy, Christine Lacabaratz, Kim Ellefsen-Lavoie, Wolfgang Stöhr, Jean-Daniel Lelièvre, et al.. Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial. PLoS Pathogens, 2020, 16 (6), pp.e1008522. ⟨10.1371/journal.ppat.1008522⟩. ⟨hal-03142733⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM INRIA UPEC INRIA2 U1219
26 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More